Does DALFAMPRIDINE Cause Multiple sclerosis relapse? 3,322 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,322 reports of Multiple sclerosis relapse have been filed in association with DALFAMPRIDINE (Dalfampridine). This represents 5.9% of all adverse event reports for DALFAMPRIDINE.
3,322
Reports of Multiple sclerosis relapse with DALFAMPRIDINE
5.9%
of all DALFAMPRIDINE reports
29
Deaths
1,234
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From DALFAMPRIDINE?
Of the 3,322 reports, 29 (0.9%) resulted in death, 1,234 (37.1%) required hospitalization, and 15 (0.5%) were considered life-threatening.
Is Multiple sclerosis relapse Listed in the Official Label?
Yes, Multiple sclerosis relapse is listed as a known adverse reaction in the official FDA drug label for DALFAMPRIDINE.
What Other Side Effects Does DALFAMPRIDINE Cause?
Gait disturbance (8,780)
Drug ineffective (6,794)
Fall (5,554)
Therapy cessation (4,580)
Fatigue (3,778)
Balance disorder (3,753)
Condition aggravated (3,240)
Dizziness (2,959)
Urinary tract infection (2,757)
Insomnia (2,546)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
PEGINTERFERON BETA-1A (945)
Which DALFAMPRIDINE Alternatives Have Lower Multiple sclerosis relapse Risk?
DALFAMPRIDINE vs DALTEPARIN
DALFAMPRIDINE vs DAMOCTOCOG ALFA PEGOL
DALFAMPRIDINE vs DANAPAROID
DALFAMPRIDINE vs DANAZOL
DALFAMPRIDINE vs DANICOPAN